Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intermolecular is a materials science company that specializes in advanced experimentation and data analysis to accelerate the discovery and development of new materials. Acquired by Merck KGaA in 2019, the company utilizes its proprietary High Productivity Combinatorial (HPC) platform to provide R&D services and technology for the semiconductor, consumer electronics, and specialty chemicals industries. Their approach combines high-throughput synthesis, characterization, and informatics to significantly reduce the time-to-market for complex material systems. While primarily focused on electronics, their methodologies share similarities with combinatorial chemistry used in drug discovery and are increasingly applied to specialty chemical sectors including pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intermolecular.